Risk factors
Pulmatrix (PULM) risk factors
Item 1A of every Pulmatrix, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors68 risks2 dropped4 reworded
Merger-related risks 10 and 11 were removed, indicating the transaction has progressed beyond restrictions on competing deals and interim actions.
Filed Feb 26, 2026 - FY2024 10-K risk factors70 risks
Pulmatrix is heavily focused on completing its pending merger with Cullgen, issuing shares, and executing a reverse stock split. The company is actively seeking to divest its remaining legacy clinical programs, PUR3100 and PUR1800. Operations face ongoing net losses, historical deficits, and a substantial reliance on future capital raises.
Filed Mar 21, 2025